Financhill
Back

iShares MSCI All Country Asia ex Jpn ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
46

AAXJ
iShares MSCI All Country Asia ex Jpn ETF

Last Price:
74.26
Seasonality Move:
1.52%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Sell
46
iShares MSCI All Country Asia ex Jpn ETF (AAXJ) is a Sell

Is iShares MSCI All Country Asia ex Jpn ETF a Buy, Sell or Hold?

  • The current iShares MSCI All Country Asia ex Jpn ETF [AAXJ] share price is $74.20. The Score for AAXJ is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • AAXJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AAXJ Stock Price Chart

What is iShares MSCI All Country Asia ex Jpn ETF's stock price today?

  • The iShares MSCI All Country Asia ex Jpn ETF share price today is $74.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AAXJ is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

AAXJ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.79 Sell
Relative Strength Index (14 RSI): 42.93 Sell
Chaikin Money Flow: 536966 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.85 - 76.91) Sell
Bollinger Bands (100): (71.28 - 77.6) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

AAXJ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.09 Buy
20-day SMA: 75.02 Sell
50-day SMA: 76.93 Sell
200-day SMA: 71.94 Buy
8-day EMA: 74.14 Buy
20-day EMA: 74.87 Sell
50-day EMA: 75.41 Sell
200-day EMA: 72.47 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

iShares MSCI All Country Asia ex Jpn ETF Earnings Growth & AAXJ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

iShares MSCI All Country Asia ex Jpn ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):